Livingston Group Asset Management CO operating as Southport Capital Management Trims Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Livingston Group Asset Management CO operating as Southport Capital Management lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 58.1% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 3,123 shares of the healthcare conglomerate’s stock after selling 4,339 shares during the period. Livingston Group Asset Management CO operating as Southport Capital Management’s holdings in UnitedHealth Group were worth $1,220,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the stock. FMR LLC grew its position in shares of UnitedHealth Group by 0.6% during the second quarter. FMR LLC now owns 50,452,463 shares of the healthcare conglomerate’s stock worth $20,203,185,000 after purchasing an additional 291,660 shares in the last quarter. State Street Corp grew its position in shares of UnitedHealth Group by 1.9% during the second quarter. State Street Corp now owns 44,530,535 shares of the healthcare conglomerate’s stock worth $17,831,807,000 after purchasing an additional 838,941 shares in the last quarter. Geode Capital Management LLC grew its position in shares of UnitedHealth Group by 4.7% during the second quarter. Geode Capital Management LLC now owns 15,110,522 shares of the healthcare conglomerate’s stock worth $6,033,290,000 after purchasing an additional 679,484 shares in the last quarter. Bank of New York Mellon Corp grew its position in shares of UnitedHealth Group by 3.8% during the second quarter. Bank of New York Mellon Corp now owns 9,579,497 shares of the healthcare conglomerate’s stock worth $3,836,011,000 after purchasing an additional 354,695 shares in the last quarter. Finally, Morgan Stanley grew its holdings in UnitedHealth Group by 9.7% during the 2nd quarter. Morgan Stanley now owns 8,693,237 shares of the healthcare conglomerate’s stock valued at $3,481,120,000 after buying an additional 768,188 shares in the last quarter. Hedge funds and other institutional investors own 86.20% of the company’s stock.

In related news, Director Stephen J. Hemsley sold 75,000 shares of the business’s stock in a transaction on Monday, October 25th. The stock was sold at an average price of $448.72, for a total transaction of $33,654,000.00. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction on Tuesday, September 14th. The stock was sold at an average price of $416.75, for a total value of $1,041,875.00. Following the transaction, the director now owns 154,403 shares in the company, valued at $64,347,450.25. The disclosure for this sale can be found here. Insiders sold a total of 82,500 shares of company stock worth $36,855,125 over the last quarter. Company insiders own 0.55% of the company’s stock.

NYSE UNH traded up $3.03 on Thursday, reaching $450.16. 2,248,836 shares of the stock traded hands, compared to its average volume of 2,940,181. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.77 and a current ratio of 0.77. The company has a fifty day moving average price of $430.47 and a 200-day moving average price of $418.01. The company has a market cap of $423.98 billion, a price-to-earnings ratio of 27.93, a PEG ratio of 1.75 and a beta of 0.85. UnitedHealth Group Incorporated has a 12 month low of $320.35 and a 12 month high of $466.00.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share for the quarter, beating the Zacks’ consensus estimate of $4.41 by $0.11. The business had revenue of $72.34 billion during the quarter, compared to analyst estimates of $71.24 billion. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. UnitedHealth Group’s revenue was up 11.1% on a year-over-year basis. During the same period in the previous year, the company posted $3.51 EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 14th. Stockholders of record on Monday, December 6th will be issued a $1.45 dividend. The ex-dividend date is Friday, December 3rd. This represents a $5.80 dividend on an annualized basis and a dividend yield of 1.29%. UnitedHealth Group’s dividend payout ratio is presently 35.98%.

Several research firms have weighed in on UNH. Morgan Stanley raised their price target on UnitedHealth Group from $488.00 to $499.00 and gave the company an “overweight” rating in a report on Friday, October 15th. Oppenheimer raised their price objective on UnitedHealth Group from $465.00 to $475.00 and gave the company an “outperform” rating in a research note on Friday, October 15th. Credit Suisse Group raised their price objective on UnitedHealth Group from $462.00 to $495.00 and gave the company an “outperform” rating in a research note on Friday, October 15th. Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $421.00 to $477.00 and gave the company a “buy” rating in a research note on Tuesday, November 16th. Finally, SVB Leerink initiated coverage on UnitedHealth Group in a research note on Monday, September 27th. They issued an “outperform” rating and a $480.00 price objective for the company. One analyst has rated the stock with a hold rating, twenty-one have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $477.35.

UnitedHealth Group Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

See Also: Holder of Record

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.